Literature DB >> 10812164

Transposition of duplicated chromosomal segment involving fused BCR-ABL gene or ABL oncogene alone in chronic myelocytic leukemia and Ph chromosome-positive acute leukemia with complex karyotypes.

K Tanaka1, M Arif, T Kyo, H Dohy, N Kamada.   

Abstract

Thirty-six patients with chronic myelocytic leukemia (CML) in the blastic phase were examined by fluorescence in situ hybridization to clarify the mechanisms of progression of the disease. Two of 19 CML patients in the blastic phase (10.5%) had an extra fused BCR-ABL gene on structurally complex chromosome aberrations in addition to the Ph chromosome. Another patient had an extra ABL oncogene on the end of a deleted chromosome, resulting in three copies of the ABL oncogene. These three patients showed additional chromosome aberrations, such as der(12), der(15), and der(18), which differ from the standard karyotypic evolution in the blastic phase. Amplification of the fused BCR-ABL gene or the ABL oncogene seemed to be induced by transposition. These segmental transpositions suggest that these regions have high genetic instability possibly leading to blastic transformation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10812164     DOI: 10.1016/s0165-4608(99)00206-x

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  3 in total

1.  Location of the BCR/ABL Fusion Genes on Both Chromosomes 9 in Ph Negative Young CML Patients: An Indian Experience.

Authors:  Manisha M Brahmbhatt; Pina J Trivedi; Dharmesh M Patel; Shilin N Shukla; Prabhudas S Patel
Journal:  Indian J Hematol Blood Transfus       Date:  2014-01-22       Impact factor: 0.900

2.  Imatinib-resistant chronic myeloid leukemia (CML): Current concepts on pathogenesis and new emerging pharmacologic approaches.

Authors:  Peter Valent
Journal:  Biologics       Date:  2007-12

3.  New complex chromosomal translocation in chronic myeloid leukaemia: t(9;18;22)(q34;p11;q11).

Authors:  Abdeljabar El Andaloussi; Chrystele Bilhou-Nabera
Journal:  J Biomed Biotechnol       Date:  2007
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.